George Frey/Bloomberg via Getty Images

Here's The Latest in Health Care:

•  On Thursday, the Food and Drug Administration approved the first identical, generic version of the EpiPen. The device enables people who are experiencing potentially life-threatening allergic reactions to automatically inject epinephrine into the thigh. The cost and availability is said to improve significantly compared to the current EpiPen, made by Mylan.  Read More

•  Expect digital medicine to be reshaped by open APIs, FHIR, and cloud computing in the coming years. Big tech giants such as Amazon, Google, and Salesforce have publicly pledged to use HL7's FHIR and Argonaut specifications to advance health information interoperability. The biggest piece of this digital health revolution? Unleashing the power of consumerism.   Read More

•  On Thursday, NYU School of Medicine announced that it will be covering tuition for all its medical students regardless of financial need. It is the first and only top-1o ranked med school in the U.S. to offer this kind of financial assistance. The move is aimed to encourage students to pursue specialties such as family practice and pediatrics, which are much less lucrative and tend to have a shortage of physicians.  Read More

•  According to a new study, the more weight loss, the better. Study participants that were overweight or obese and who lost a higher percentage of weight presented a much lower risk for metabolic syndrome than those who maintained less than a 5 percent weight loss.  Read More

Each Friday, Signor Goat reports the latest from the week in health care. Check back next Friday for your dose of our little medical corner of health care news. Brought to you by pMD, innovators in charge capture, secure messaging, clinical communication, MIPS registry, clinically integrated network, and care navigation software.

‍